Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes.
about
Physiological and Pharmacological Roles of FGF21 in Cardiovascular DiseasesFibroblast Growth Factor 21 Protects against Atherosclerosis via Fine-Tuning the Multiorgan CrosstalkFibroblast Growth Factor 21 Analogs for Treating Metabolic Disorders.Exercise effects on perivascular adipose tissue: endocrine and paracrine determinants of vascular function.Assessed and Emerging Biomarkers in Stroke and Training-Mediated Stroke Recovery: State of the Art.Measuring myokines with cardiovascular functions: pre-analytical variables affecting the analytical output.Contribution of serum FGF21 level to the identification of left ventricular systolic dysfunction and cardiac death.New insights about the putative role of myokines in the context of cardiac rehabilitation and secondary cardiovascular prevention.The Role of Adipocytokines in Coronary Atherosclerosis.The Potential Role of Fibroblast Growth Factor 21 in Lipid Metabolism and Hypertension.Fibroblast Growth Factor 21 Mimetics for Treating Atherosclerosis.A high circulating FGF21 level as a prognostic marker in patients with acute myocardial infarctionFibroblast growth factor 21 inhibits atherosclerosis in apoE-/- mice by ameliorating Fas-mediated apoptosis
P2860
Q26744232-5C4E8CF0-569D-4D44-90C5-0CB422A41F9EQ26766528-6B8B20F8-96EF-414E-9BC3-29BC77C3C9FDQ27686803-917E8618-AA58-4E91-BD70-60E4E1F161C2Q30238666-6DBE385A-89FC-4174-8B19-237DFDFA79B2Q37714724-C088E966-1DD0-46B0-9541-B3F571F2AF6FQ38601292-8713904F-2BD3-45D5-A9D5-4556C5D877B0Q38618204-61B49DB9-D3E4-4443-B7C8-B53712FC19C5Q38635300-41C19ECC-75D4-4956-88F2-B7D193160CD9Q39129323-D43DFC72-039A-422B-ABC8-99E52255E895Q39197925-6CDFB3E9-51D7-4CFE-B33C-868577395BCDQ39325845-2FA074E4-0125-4D8A-95AF-64FA85EEDCFFQ57493364-38C8BD38-0708-4859-B4B2-5808BEB66B8EQ58696543-F0D31A2D-3A0C-4FCA-AE1B-529F70247054
P2860
Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Serum fibroblast growth factor ...... patients with type 2 diabetes.
@ast
Serum fibroblast growth factor ...... patients with type 2 diabetes.
@en
type
label
Serum fibroblast growth factor ...... patients with type 2 diabetes.
@ast
Serum fibroblast growth factor ...... patients with type 2 diabetes.
@en
prefLabel
Serum fibroblast growth factor ...... patients with type 2 diabetes.
@ast
Serum fibroblast growth factor ...... patients with type 2 diabetes.
@en
P2093
P2860
P1476
Serum fibroblast growth factor ...... patients with type 2 diabetes.
@en
P2093
Lingjiao Liu
Pengcheng Zhou
Weili Tang
Xiaoyan Chen
Zhaofeng Long
Zhiguang Zhou
P2860
P2888
P356
10.1186/S12933-015-0229-9
P407
P50
P577
2015-06-06T00:00:00Z
P5875
P6179
1041271532